Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Melanoma Skin Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Active Not RecruitingNCT05238883
What this trial is testing

HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

Who this might be right for
Gastric CancerRenal Cell CarcinomaMelanoma+6 more
HiFiBiO Therapeutics 72
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Early research (Phase 1)Ended earlyNCT04234113
What this trial is testing

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Thyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more
SOTIO Biotech AG 115
Testing effectiveness (Phase 2)Study completedNCT02085070
What this trial is testing

MK-3475 in Melanoma and NSCLC Patients With Brain Metastases

Who this might be right for
MelanomaNon-Small Cell Lung CancerBrain Metastases
Yale University 65
Testing effectiveness (Phase 2)UnknownNCT03544723
What this trial is testing

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Who this might be right for
Solid TumorLymphoma
MultiVir, Inc. 40
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Not applicableLooking for participantsNCT06272864
What this trial is testing

BostonGene and Exigent Genomic INsight Study

Who this might be right for
Breast CancerNon-small Cell Lung CancerMelanoma+1 more
BostonGene 400
Not applicableLooking for participantsNCT07661966
What this trial is testing

Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade

Who this might be right for
Melanoma (Skin Cancer)NSCLC (Non-small Cell Lung Cancer)
Weill Medical College of Cornell University 12
Early research (Phase 1)Active Not RecruitingNCT05614102
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 284
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Early research (Phase 1)Study completedNCT02783300
What this trial is testing

An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma

Who this might be right for
Neoplasms
GlaxoSmithKline 297
Testing effectiveness (Phase 2)Active Not RecruitingNCT07023731
What this trial is testing

Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

Who this might be right for
KRAS G12D MutationAdvanced Solid Cancer
Arvinas Inc. 76
Early research (Phase 1)Study completedNCT02498665
What this trial is testing

DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesGlioblastoma Multiforme+6 more
Sumitomo Pharma America, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT02658890
What this trial is testing

An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread

Who this might be right for
Advanced CancerMelanomaNon-Small Cell Lung Cancer
Bristol-Myers Squibb 627
Not applicableLooking for participantsNCT03740503
What this trial is testing

Genomic Investigation of Unusual Responders

Who this might be right for
CancerBreast CancerNon-small Cell Lung Cancer+8 more
University Health Network, Toronto 100
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Not applicableEnrolling By InvitationNCT00068003
What this trial is testing

Harvesting Cells for Experimental Cancer Treatments

Who this might be right for
MelanomaGastrointestinal CancerMetastatic Cancer+2 more
National Cancer Institute (NCI) 7,000
Testing effectiveness (Phase 2)Ended earlyNCT04434560
What this trial is testing

Neoadjuvant Immunotherapy in Brain Metastases

Who this might be right for
Brain Metastases, Adult
Sarah Sammons, MD 1
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Next Page